Found 7 matching trials
Individual Patient Expanded Access for AB-SA01, an Investigational Anti-Staphylococcus Aureus Bacteriophage Therapeutic N/A The purpose of the expanded access program is to allow physicians to provid...
Show More Status
No Longer Available
Location
Multiple Locations
Learn More & Join Trial
Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia PHASE1 Phase 1b/2a, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascendi...
Show More Location
Banner University Medical Center
Learn More & Join Trial
Standard Treatment Associated With Phage Therapy Versus Placebo for Diabetic Foot Ulcers Infected by S. Aureus PHASE1 The primary objective of this study is to compare the efficacy of standard ...
Show More Location
CHU de Bordeaux - Hôpital Pellegrin
Learn More & Join Trial
Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia N/A Phage Treatment in Covid-19 Patients with Bacterial Co-Infections...
Status
No Longer Available
Location
Multiple Locations
Learn More & Join Trial
Phage Therapy in Prosthetic Joint Infection Due to Staphylococcus Aureus Treated With DAIR. PHASE2 Pilot non comparative study assessing the clinical control of infection of ...
Show More Learn More & Join Trial
Proof of Concept Study to Assess Safety and Efficacy of Phage Therapy in Hip or Knee Prosthetic Joint Infections Due to Staphylococcus Aureus Treated by DAIR. PHASE2 Total joint replacements are effective for chronic pain but can lead to Pro...
Show More Location
Multiple Locations
Learn More & Join Trial
Bacteriophage Therapy for Staphylococcus Lugdunensis Prosthetic Joint Infection PHASE1 This is a single-patient, phase I/II clinical trial that aims to evaluate t...
Show More Location
Foothills Medical Centre, University of Calgary
Learn More & Join Trial